CAFERGOT DISCONTINUED NO FURTHER A MYSTERY

ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) will raise the level or impact of ergotamine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Acute ergot toxicity characterized by vasospasm and tissue ischemia continues to be associated with coadministration of ritonavirergotamine will enhance the degree or impact of t